Week in Review: The power and potential of PET/CT | Imaging of non-small cell lung cancer | News roundup from JFR 2022

Dear AuntMinnieEurope Member,

In the fast-moving world of news gathering, writing, and editing in which I work, there's hardly ever time to linger long over a clinical image. But this week I found myself deeply moved by a case provided by researchers from Madrid.

A 26-year-old man had presented with fever and night sweats. It took PET/CT to make the diagnosis of non-Hodgkin's lymphoma. I thought about the shock and inner turmoil felt by the young man and his family and friends. I wondered how all of them had coped with the news and how they were dealing with the implications.

If you're curious about the figure that had such an impact on me, you can view it in this week's top article.

Also in our ever popular Molecular Imaging Community, you can read a report on how best to use PET/CT and optimize techniques in patients with non-small cell lung cancer. This story focuses on the experiences of radiologists in the U.K., Italy, and Egypt.

The French national radiology congress (JFR) drew to a close earlier in the week. This year's meeting was fully onsite, and it was not possible to listen to sessions online. Thankfully Mélisande Rouger was in Paris to cover the conference for us. Don't miss her video interviews with three leading figures in French radiology: Prof. Martine Rémy-Jardin from Lille, Prof. Denis Le Bihan from Gif-sur-Yvette, and Prof. Afshin Gangi from Strasbourg.

Last but not least, we've posted an article from JFR 2022 about the latest developments in prostate MRI and transurethral ablation. Gangi was a speaker and moderator at that session, and he spoke about his enthusiasm for a promising new technique. Get the full story in the MRI Community.

Page 1 of 114
Next Page